Caterina Bertucci is a seasoned professional in the biotech industry, serving as the Founder and President of 4orty2wo, LLC, where she leverages her extensive 20 years of scientific research experience to provide unparalleled consulting services in diagnostic and screening program management. With a robust background...
Caterina Bertucci is a seasoned professional in the biotech industry, serving as the Founder and President of 4orty2wo, LLC, where she leverages her extensive 20 years of scientific research experience to provide unparalleled consulting services in diagnostic and screening program management. With a robust background in genomics, computational analysis, and immunodiagnostics, Caterina has honed her expertise in the development of in vitro diagnostics (IVD) and navigating the complexities of FDA submissions, including Premarket Approval (PMA) and 510(k) processes.
At 4orty2wo, Caterina leads key projects that focus on advancing innovative diagnostic solutions, emphasizing high-throughput screening and PCR technologies. Her deep understanding of immunology and genetics allows her to guide biotech companies through the intricacies of product development, ensuring compliance with regulatory standards while optimizing project planning and execution. Caterina's strategic vision and account management skills enable her to foster strong partnerships with clients, helping them to navigate the rapidly evolving landscape of life sciences.
Her commitment to excellence is evident in her ability to translate complex scientific concepts into actionable insights, making her a sought-after consultant in the biotech field. Caterina’s leadership at 4orty2wo not only reflects her passion for advancing diagnostic technologies but also her dedication to empowering organizations to achieve their goals in a competitive market. As she continues to drive innovation and support the development of cutting-edge diagnostic tools, Caterina Bertucci remains a pivotal figure in the realm of biotechnology and diagnostics.
